Loading...
NPI 1427062256 · Port Angeles, WA · Community/Retail Pharmacy
Customize your policy alerts
Get alerted when relevant policies change without checking for updates manually.
Monitor payer policy activity
Cammacks Pharmacies Inc is a community/retail pharmacy provider located in Port Angeles, Washington. This profile covers 10 Medicare and 31 Medicaid CPT/HCPCS procedure codes, with claims volume, average reimbursement, and total revenue by code, benchmarked against other providers billing the same services.
Provider details (source: NPPES NPI Registry)
| Field | Value |
|---|---|
| Entity Type | Organization |
| Organization | Cammacks Pharmacies Inc |
| Address | 424 E 2nd St |
| City | Port Angeles |
| State | WA |
| ZIP | 98362 |
| Taxonomy | Community/Retail Pharmacy |
| NPI Enumerated | July 28, 2006 |
Lifetime revenue by payer source (source: CMS Medicare & Medicaid claims data)
| Payer Source | Total Paid |
|---|---|
| Medicaid | $463.5K |
| Medicare | $165.9K |
Medicare revenue breakdown by CPT/HCPCS procedure code.
View: Bar Chart1 / 2
The CPT/HCPCS codes generating the most Medicare revenue for this provider.
10 rows
| CPT/HCPCS Code | Description | Claims | Avg Paid | Revenue |
|---|---|---|---|---|
| 91320 | This code represents a SARS–CoV–2 vaccine product (tris–sucrose formulation) administered by intramuscular injection to reduce the patient’s risk of contracting COVID–19. The dosage is 30 mcg/0.3 mL. | 380 | $130 | $48.5K |
| 90662 | This code represents a flu vaccine product that is a split virus type, contains no preservatives, and has enhanced effectiveness due to a higher antigen content. It is administered as an injection… | 540 | $70 | $39K |
| 91322 | This code represents a SARS–CoV–2 vaccine product administered by intramuscular injection to reduce the patient’s risk of contracting COVID–19. The dosage is 50 mcg/0.5 mL. | 150 | $140 | $21.9K |
| 90480 | The provider administers the first or only component of a SARS–CoV–2 (COVID–19) vaccine by intramuscular injection to reduce the patient's risk of contracting COVID–19. | 530 | $40 | $20.7K |
| G0008 | Administration of influenza virus vaccine | 590 | $30 | $18.2K |
| 90677 | This code represents a vaccine product administered intramuscularly to protect against pneumococcal disease, a bacterial infection. This is a 20–valent vaccine, protecting against 20 strains of the… | 40 | $280 | $9.7K |
| 0134A | N/A | 140 | $40 | $5.3K |
| G0009 | Administration of pneumococcal vaccine | 40 | $30 | $1.1K |
| 90686 | This code represents a vaccine product administered into the muscle to protect against four strains of influenza (flu). It is preservative free, uses split virus technology, and is given as a 0.5 mL… | 50 | $20 | $990 |
| 0124A | N/A | 10 | $40 | $430 |
How this provider's Medicare billing volume and revenue compare to other providers nationally and within its state, across 10 CPT/HCPCS codes.
View: State1 / 2
Full comparison — all codes billed, vs. state median
Medicaid revenue breakdown by year and by CPT/HCPCS procedure code, including monthly billing trends and the top codes driving revenue.
View: By Year1 / 3
Every CPT/HCPCS code this provider has billed to Medicaid, with claims volume, average payment, and total revenue.
31 rows
| CPT/HCPCS Code | Description | Claims | Avg Paid | Revenue |
|---|---|---|---|---|
| E0601 | Continuous positive airway pressure (CPAP) device | 1,390 | $70 | $94.2K |
| E1390 | Oxygen concentrator, single delivery port, capable of delivering 85 percent or greater oxygen concentration at the prescribed flow rate | 1,190 | $40 | $52.4K |
| A4604 | Tubing with integrated heating element for use with positive airway pressure device | 1,430 | $30 | $43K |
| T4541 | Incontinence product, disposable underpad, large, each | 1,310 | $30 | $40.6K |
| T4528 | Adult sized disposable incontinence product, protective underwear/pull-on, extra large size, each | 410 | $100 | $39.5K |
| A4927 | Gloves, non-sterile, per 100 | 2,430 | $20 | $36.5K |
| E0570 | Nebulizer, with compressor | 2,240 | $10 | $29.1K |
| A7035 | Headgear used with positive airway pressure device | 1,090 | $20 | $22.9K |
| T4526 | Adult sized disposable incontinence product, protective underwear/pull-on, medium size, each | 240 | $80 | $19K |
| T4535 | Disposable liner/shield/guard/pad/undergarment, for incontinence, each | 410 | $40 | $16.6K |
Showing 1–10 of 31
How this provider's Medicaid billing volume and revenue compare to other Washington providers billing the same CPT/HCPCS codes.
Full comparison — all codes billed, vs. Washington median
31 rows
| CPT/HCPCS Code | Description | Rank | Provider Count | Median Claims | Avg Paid | Average Revenue |
|---|---|---|---|---|---|---|
| T4527 | Adult sized disposable incontinence product, protective underwear/pull-on, large size, each | 42 | 50 | 1,230 | $90 | $667.8K |
| T4528 | Adult sized disposable incontinence product, protective underwear/pull-on, extra large size, each | 30 | 40 | 1,140 | $90 | $504.3K |
| T4526 | Adult sized disposable incontinence product, protective underwear/pull-on, medium size, each | 39 | 50 | 920 | $70 | $497.1K |
| T4541 | Incontinence product, disposable underpad, large, each | 30 | 60 | 1,310 | $40 | $433.9K |
| E1390 | Oxygen concentrator, single delivery port, capable of delivering 85 percent or greater oxygen concentration at the prescribed flow rate | 55 | 80 | 4,270 | $50 | $417K |
| T4537 | Incontinence product, protective underpad, reusable, bed size, each | 48 | 50 | 2,140 | $40 | $416.6K |
| A4927 | Gloves, non-sterile, per 100 | 45 | 80 | 2,930 | $20 | $408K |
| T4535 | Disposable liner/shield/guard/pad/undergarment, for incontinence, each | 42 | 60 | 1,620 | $30 | $368.3K |
| E0601 | Continuous positive airway pressure (CPAP) device | 58 | 90 | 1,970 | $70 | $242.5K |
| A7030 | Full face mask used with positive airway pressure device, each | 76 | 80 | 1,050 | $80 | $125.7K |
Showing 1–10 of 31
Other providers in the same ZIP code as Cammacks Pharmacies Inc, ranked by combined Medicare and Medicaid revenue.
Trek Health ingests and normalizes Transparency in Coverage data and payer policy updates to give provider organizations a clear view of how commercial reimbursement behaves across markets, payers, and services. Our platform transforms raw payer disclosures into structured intelligence that supports contract evaluation, payer negotiations, and service line strategy. By combining market benchmarks with ongoing policy visibility, Trek helps teams identify variability, risk, and opportunity in commercial reimbursement. The result is faster insight, stronger negotiating positions, and more informed financial decisions.